CRDL vs. INVZ
CRDL (Cardiol Therapeutics Inc Class A) and INVZ (Innoviz Technologies Ltd.) are both stocks. CRDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while INVZ operates in Auto Parts (Consumer Cyclical). Over the past 5 years, CRDL returned -15.86%/yr vs -43.40%/yr for INVZ. At a 0.20 correlation, their price movements are largely independent.
Performance
CRDL vs. INVZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRDL achieves a 10.09% return, which is significantly higher than INVZ's -28.50% return.
CRDL
- 1D
- -0.94%
- 1M
- -20.45%
- YTD
- 10.09%
- 6M
- 5.00%
- 1Y
- -17.97%
- 3Y*
- 8.09%
- 5Y*
- -15.86%
- 10Y*
- —
INVZ
- 1D
- 1.48%
- 1M
- -14.02%
- YTD
- -28.50%
- 6M
- -38.15%
- 1Y
- -54.48%
- 3Y*
- -38.32%
- 5Y*
- -43.40%
- 10Y*
- —
CRDL vs. INVZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRDL Cardiol Therapeutics Inc Class A | 10.09% | -25.48% | 51.80% | 65.33% | -72.43% | -47.29% |
INVZ Innoviz Technologies Ltd. | -28.50% | -49.22% | -33.60% | -35.62% | -38.01% | -34.84% |
Correlation
The correlation between CRDL and INVZ is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 2021 | 0.20 |
Fundamentals
CRDL:
$105.27M
INVZ:
$131.46M
CRDL:
-CA$0.38
INVZ:
-$0.39
CRDL:
8.37
INVZ:
2.20
CRDL:
CA$0.00
INVZ:
$44.83M
CRDL:
-CA$25.95K
INVZ:
$4.34M
CRDL:
-CA$34.00M
INVZ:
-$73.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRDL vs. INVZ — Risk / Return Rank
CRDL
INVZ
CRDL vs. INVZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and Innoviz Technologies Ltd. (INVZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRDL | INVZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.35 | ||
| Sortino ratioReturn per unit of downside risk | +0.81 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 0.92 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | -0.45 | -0.72 | +0.27 |
| Martin ratioReturn relative to average drawdown | -0.64 | -1.09 | +0.45 |
Loading charts...
Drawdowns
CRDL vs. INVZ - Drawdown Comparison
The maximum CRDL drawdown since its inception was -92.71%, roughly equal to the maximum INVZ drawdown of -96.06%. Use the drawdown chart below to compare losses from any high point for CRDL and INVZ.
Loading charts...
Drawdown Indicators
| CRDL | INVZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.71% | -96.06% | +3.35% |
Max Drawdown (1Y)Largest decline over 1 year | -39.87% | -75.55% | +35.68% |
Max Drawdown (3Y)Largest decline over 3 years | -72.73% | -88.12% | +15.39% |
Max Drawdown (5Y)Largest decline over 5 years | -90.72% | -95.39% | +4.67% |
Current DrawdownCurrent decline from peak | -83.04% | -95.06% | +12.02% |
Average DrawdownAverage peak-to-trough decline | -69.03% | -74.96% | +5.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.09% | 49.88% | -21.79% |
Volatility
CRDL vs. INVZ - Volatility Comparison
The current volatility for Cardiol Therapeutics Inc Class A (CRDL) is 10.52%, while Innoviz Technologies Ltd. (INVZ) has a volatility of 16.37%. This indicates that CRDL experiences smaller price fluctuations and is considered to be less risky than INVZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRDL | INVZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.52% | 16.37% | -5.85% |
Volatility (6M)Calculated over the trailing 6-month period | 40.08% | 58.47% | -18.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.84% | 88.81% | -19.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.06% | 89.13% | -2.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.79% | 88.68% | -1.89% |
Dividends
CRDL vs. INVZ - Dividend Comparison
Neither CRDL nor INVZ has paid dividends to shareholders.
Financials
CRDL vs. INVZ - Financials Comparison
This section allows you to compare key financial metrics between Cardiol Therapeutics Inc Class A and Innoviz Technologies Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRDL and INVZ have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INVZ has higher volatility (16.37%) compared to CRDL (10.52%). In terms of maximum drawdown, CRDL dropped -92.71% vs INVZ's -96.06%.
CRDL currently has the higher Sharpe Ratio (-0.26 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRDL and INVZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer